Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Pathology|April 13, 2023
MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinomaSahithi Tadi, Veronica Ka-Yan Cheung, C Soon Lee, et al.Cancer Reports (Hoboken, N.J.)|December 14, 2020
PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcomaTahlia Scheinberg, Anna Lomax, Martin Tattersall, et al.Journal of Surgical Oncology|March 15, 2021
A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter studyArdalan Ebrahimi, Peter P Luk, Hubert Low, et al.Gynecologic Oncology|June 17, 2015
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cellsStéphanie Decollogne, Swapna Joshi, Sylvia A Chung, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 13, 2016
Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glandsPeter P Luk, James Wykes, Christina I Selinger, et al.Head & Neck|August 26, 2020
The American Joint Committee on Cancer staging for metastatic head and neck cutaneous squamous cell carcinoma: A multi-institutional study of within-stage heterogeneity and impact on prognostic performanceArdalan Ebrahimi, Peter P Luk, Hubert Low, et al.Head & Neck|December 25, 2015
Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutationsPeter P Luk, Jared D Weston, Bing Yu, et al.Pathology|February 28, 2021
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian populationNimeka Ramanayake, Ana Cristina Vargas, Joel Talbot, et al.Head and Neck Pathology|March 18, 2026
International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR InitiativeBeth M Beadle, Nazim Benzerdjeb, Junhun Cho, et al.Oncotarget|November 5, 2017
Somatic mutations in salivary duct carcinoma and potential therapeutic targetsTimothy K Khoo, Bing Yu, Joel A Smith, et al.Pageof 3